Inhibitory effects of angiotensin-converting enzyme (ACE) inhibitors on oxygen radicals produced by bronchoalveolar lavage cells in young and aged guinea pigs

Aging Clinical and Experimental Research

Volumn 12, Issue 1, 2000, Pages 22-28

  Teramoto, S ^a   Suzuki, M ^a   Matsuse, T ^b   Ohga, E ^a   Ishii, T ^a   Ouchi, Y ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

ACE inhibitors; Age; Alacepril; Lisinopril; Lung disease; Oxygen radicals

Indexed keywords

ALACEPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; OXYGEN RADICAL; PHORBOL 13 ACETATE 12 MYRISTATE;

ADOLESCENT; AGE; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CELL COUNT; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; GUINEA PIG; IC 50; LUNG ALVEOLUS MACROPHAGE; LUNG DISEASE; LUNG LAVAGE; MALE; NONHUMAN;

ANIMALIA; CAVIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0034050557     PISSN: 03949532     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03339824     Document Type: Article

References (39)

1. Janssen Y.M., Van-Houten B., Borm P.J., Mossman B.T.: Cell and tissue responses to oxidative damage. Lab. Invest. 68: 261-274, 1993.
2. Richter C., Gogvadze V., Laffranchi R., Schlapbach R., Schweizer M., Suter M., Walter P., Yaffee M.: Oxidants in mitochondria: from physiology to diseases. Biochim. Biophys. Acta 1271: 67-74, 1995.
3. Poli G., Parola M.: Oxidative damage and fibrogenesis. Free Radic. Biol. Med. 22: 287-305, 1997.
4. Rahman I., Morrison D., Donaldson K., MacNee W.: Systemic oxidative stress in asthma, COPD, and smokers. Am. J. Respir. Crit. Care Med. 154: 1055-1060, 1996.
5. Teramoto S., Fukuchi Y., Uejima Y., Chu C-Y., Orimo H.: Superoxide anion formation and glutathione metabolism of blood in patients with idiopathic pulmonary fibrosis. Biochem. Mol. Med. 55: 66-70, 1995.
6. Teramoto S., Shu C-Y., Ouchi H., Fukuchi Y.: Increased spontaneous production and generation of superoxide anion by blood neutrophils in patients with asthma. J. Asthma 33: 149-155, 1996.
7. Dekhuijzen P.N., Aben K.K., Dekker I., Aarts L.P., Wielders P.L., van-Herwaarden C.L., Bast A.: Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 154: 813-816, 1996.
8. Repine J.E., Bast A., Lankhorst I., and the Oxidative Stress Study Group.: Oxidative stress in chronic obstructive pulmonary disease. Am J. Respir. Crit. Care Med. 156: 341-357, 1997.
9. Ondetti M.A., Rubin B., Cushman D.W.: Design of specific inhibitors of angiotensin-converting enzyme: New class of orally active hypertensive agents. Science 196: 441-444, 1977.
10. Williams G.H.: Converting-enzyme inhibitors in the treatment for hypertension. N. Engl. J. Med. 319: 1517-1525, 1998.
11. Kleber F.X., Wensel R.: Current guidelines for the treatment of congestive heart failure. Drugs 51: 89-98, 1996.
12. Glassock R.J.: The therapy of idiopathic membranous glomerulonephritis. Semin. Nephrol. 11: 138-147, 1991.
13. Martin M.F.R., McKenna F., Bird H.A., Surral K.E., Dixon J.S., Wright V.: Captopril: A new treatment for rheumatoid arthritis? Lancet 1: 1325-1327, 1988.
14. Hirawa N., Uehara Y., Kawabata Y., Ohshima N., Ono H., Nagata T., Gomi T., Ikeda T., Goto A., Yagi S.: Mechanistic analysis of renal protection by angiotensin converting enzyme inhibitors in Dahl salt-sensitive rats. J. Hypertens. 12: 909-918, 1994.
15. Mira M.L., Silva M.M., Queiroz M.J., Manso C.F.: Angiotensin converting enzyme inhibitors as oxygen free radical scavengers. Free Radic. Res. Commun. 19: 173-181, 1993.
16. Lapenna D., Cuccurullo F.: Captopril; Does it act as a direct antioxidant by free radical scavenging in humans? Free Radic. Biol. Med. 14: 643-647, 1993.
17. Suzuki S., Sato H., Shimada H., Takashima N., Arakawa M.: Comparative free radical scavenging action of angiotensin-converting enzyme inhibitor with and without the sulfhydryl radical. Pharmacology 47: 61-65, 1993.
18. Bartosz M., Kedziora J., Bartosz G.: Antioxidant and prooxidant properties of captopril and enalapril. Free Radic. Biol. Med. 23: 729-735, 1997.
19. Noda Y., Mori A., Packer L.: Free radical scavenging properties of alacepril metabolites and lisinopril. Res. Commun. Mol. Pathol. Pharmacol. 96: 125-136, 1997.
20. Suzuki M., Teramoto S., Matsuse T., Ohga E., Katayama H., Fukuchi Y., Ouchi Y.: Inhibitory effect of ambroxol on superoxide anion production and generation by murine alveolar macrophages. J. Asthma 35: 267-272, 1998.
21. Teramoto S., Suzuki M., Matsuse T., Ouchi Y.: Effect of ambroxol on oxygen radical production and generation of bronchoalveolar lavage cells in young and aged guinea pigs. Jpn. J. Pharmacol. 78: 424-431, 1998.
22. Teramoto S., Fukuchi Y., Shu C.Y., Orimo H.: Influences of cisplatin combination chemotherapy on oxygen radical generation by blood in elderly and adult patients with lung cancer. Chemotherapy 41: 222-228, 1995.
23. Teramoto S., Fukuchi Y., Uejima Y., Teramoto K., Orimo H.: Biochemical characteristics of lungs in senescence-accelerated mouse (SAM). Eur. Respir. J. 8: 450-456, 1995.
24. Wong H.R., Wispe J.R.: The stress response and the lung. Am. J. Physiol. 273: L1-L9, 1997.
25. Pitt B.: The potential use of angiotensin-converting enzyme inhibitors in patients with hyperlipidemia. Am. J. Cardiol. 79: 24-28, 1997.
26. Clapperton M., Beswick P.H., Abdullah I., Dargie H.J., Fisher A.C., McMurray J.: Effect of captopril, enalaprilat and mercaptopropionyl glycine (MPG) on the oxidative activity of human isolated neutrophils. Br. J. Clin. Pharmacol. 40: 31-35, 1995.
27. Ward W.F., Molteni A., Ts'ao C.H., Hinz J.M.: Captopril reduces collagen and mast cell accumulation in irradiated rat lung. Int. J. Radiat. Oncol. Biol. Phys. 19: 1405-1409, 1990.
28. Ward W.F., Lin P.J., Wong P.S., Behnia R., Jalali N.: Radiation pneumonitis in rats and its modification by the angiotensin-converting enzyme inhibitor captopril evaluated by high-resolution computed tomography. Radiat. Res. 135: 81-87, 1993.
29. Schwab R., Walters C., Weksler M.: Host defense mechanisms against aging. Semin. Oncol. 10: 20-27, 1988.
30. Corrberand J., Laharrague P.F., Fillola G.: Neutrophils of healthy aged humans are normal. Mech. Ageing Dev. 36: 57-63, 1986.
31. Lipschitz D.A., Udupa K.B.: Influence of ageing and protein deficiency on neutrophil function. J. Gerontol. 41: 690-694, 1986.
32. Preuss J.M.H., Goldie R.G.: The influence of age on isolated tracheal responsiveness to spasmogens. Eur. J. Pharmacol. 345: 71-77, 1998.
33. Ingham N.J., Thornton S.K., Withington D.J.: Age-related changes in auditory spatial properties of the guinea pig superior colliculus. Brain Res. 788: 60-68, 1998.
34. Teramoto S., Matsuse T., Oka T., Ito H., Fukuchi Y., Ouchi Y.: Investigation of effects of anesthesia and age on aspiration in mice using LacZ gene transfer by recombinant E1-deleted adenovirus vectors. Am. J. Respir. Crit. Care Med. 158: 1914-1919, 1998.
35. Teramoto S., Matsui H., Ohga E., Ishii T., Matsuse T., Ouchi Y.: A novel model of aspiration in young and aged guinea pigs using LacZ gene transduction of adenovirus vector. Br. J. Anaesth. 83: 101-107, 1999.
36. Harman D.: Aging: A theory based on free radical and radiation chemistry. J. Gerontol. 11: 298-300, 1956.
37. Shigenega M.K., Hagen T.M., Ames B.N.: Oxidative damage and mitochondrial decay in aging. Proc. Natl. Acad. Sci. USA 91: 10771-10778, 1994.
38. Teramoto S., Fukuchi Y., Uejima Y., Teramoto K., Orimo H.: Age-related changes in antioxidant screen of distal lung in mice. Lung 172: 223-230, 1994.
39. Teramoto S., Uejima Y., Teramoto K., Ouchi Y., Fukuchi Y.: Effect of age on alteration of glutathione metabolism following chronic cigarette smoke inhalation in mice. Lung 174: 119-126, 1996.